Skip to main content

Advertisement

SpringerLink
Log in

Comments on “An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer”

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Kilic N, Taslipinar MY, Guney Y, et al. An investigation into the serum thioredoxine, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer. Ann Surg Oncol. 2014;21:4139–43.

    Article  PubMed  Google Scholar 

  2. Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Okita K, et al. Crosssectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1178 middle-aged Japanese men—the Amagasaki Visceral Fat Study. Nutr Metabol. 2011;8:82.

    Article  CAS  Google Scholar 

  3. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, NEGI MPS, et al. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology. 2010;15:349–56.

    Article  PubMed  Google Scholar 

  4. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther. 2010;6:487–91.

    Article  CAS  PubMed  Google Scholar 

  5. Mahdavi R, Faramarzi E, Seyedrezazadeh E, Mohammad-Zadeh M, Pourmoghaddam M. Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients. Biol Trace Elem Res. 2009;130:1–6.

    Article  CAS  PubMed  Google Scholar 

  6. Chang D, Wang F, Zhao YS, Pan HZ. Evaluation of oxidative stress in colorectal cancer patients. Biomed Environ Sci. 2008;21:286-9.

    Article  CAS  PubMed  Google Scholar 

  7. Rasheed MH, Beevi SS, Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol. 2007;43:333–8.

    Article  CAS  PubMed  Google Scholar 

  8. Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119–23.

    Article  CAS  PubMed  Google Scholar 

  9. Gonenc A, Erten D, Aslan S, Akinci M, Sximsxek B, Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006;30:376–80.

    Article  PubMed  Google Scholar 

  10. Maldonado PA, Negrini LA, Kaizer RR, Zanin RF, Araujo MC, Battisti V, et al. Oxidative status in patients submitted to conization and radiation treatments for uterine cervix neoplasia. Clin Chim Acta. 2006;366:174–8.

    Article  CAS  PubMed  Google Scholar 

  11. Beevi SS, Rasheed MH, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol. 2004;34:379–85.

    Article  PubMed  Google Scholar 

  12. Akbulut H, Akbulut KG, Icli F, Büyükcelik A. Daily variations of plasma malondialdehyde levels in patients with early breast cancer. Cancer Detect Prev. 2003;27:122–6.

    Article  CAS  PubMed  Google Scholar 

  13. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol. 2002;32:162–6.

    Article  PubMed  Google Scholar 

  14. Subapriya R, Kumaraguruparan R, Ramachandran CR, Nagini S. Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites. Clin Biochem. 2002;35:489–93.

    Article  CAS  PubMed  Google Scholar 

  15. Hristozov D, Gadjeva V, Vlaykova T, Popova S, Dimitrov G. Evaluation of oxidative stress in patients with cancer. Arch Phys Biochem. 2001;109:331–6.

    Article  CAS  Google Scholar 

  16. Geber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr. 1996;126:1201S–7S.

    Google Scholar 

  17. Kinght JA, Smith SE, Kinder VE, Anstall HB. Reference intervals for plasma lipoperoxides: age-, sex-, and specimen-related variations. Clin Chem. 1987;33:2289–91.

    Google Scholar 

  18. Polat MF, Taysi S, Gul M, Cikman O, Yilmaz I, Bakan E, et al. Oxidant-antioxidant status in blood of patients with malignant breast tumor and benign breast disease. Cell Biochem Funct. 2002;20:327–31.

    Article  CAS  PubMed  Google Scholar 

  19. Schoenmakers AW, Tarladgis BG. Reliability of the thiobarbituric acid test in the presence of inorganic ions. Nature. 1966;210:1153.

    Article  CAS  Google Scholar 

  20. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.

    Article  CAS  PubMed  Google Scholar 

  21. Hackett C, Linley-Adams M, Lloyd B, Walker V. Plasma malondialdehyde: a poor measure of in vivo lipid peroxidation. Clin Chem. 1988;34:208.

    CAS  PubMed  Google Scholar 

  22. Kikugawa K, Kojima T, Yamaki S, Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem. 1992;202:249–55.

    Article  CAS  PubMed  Google Scholar 

  23. Antus B, Harnasi G, Drozdovszky O, Barta I. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology. 2014;19:74–9.

    Article  PubMed  Google Scholar 

  24. Halliwell B, Gutteridge JMC. Formation of a thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts the role of superoxide and hydroxyl radicals. FEBS Lett. 1981;128:343–6.

    Article  Google Scholar 

  25. Wade CR, van Rij AM. Plasma malondialdehyde, lipid peroxides, and the thiobarbituric acid reaction. Clin Chem. 1989;35:336.

    CAS  PubMed  Google Scholar 

  26. Poubelle P, Chainti-Euil J, Besadoux J, Boitman F, Simon L, Crastes de Paulet A. Plasma lipoperoxides and aging. Biomedicine. 1982;36:164–6.

    CAS  Google Scholar 

  27. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522–6.

    CAS  PubMed  Google Scholar 

  28. Gutteridge JMC. Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity. Int J Biochem. 1982;14:649–53.

    Article  CAS  PubMed  Google Scholar 

  29. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;12:302–10.

    Article  Google Scholar 

  30. Lepage P, Heckel C, Humbert S, Stahl S, Rautmann G. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem. 1991;197:277–83.

    Article  CAS  PubMed  Google Scholar 

  31. Almandos ME, Giannini DH, Ciarlo AS, Boeri RL. Formaldehyde as an interference of the 2-thiobarbituric acid test. J Sci Food Agric. 1986;37:54–8.

    Article  CAS  Google Scholar 

  32. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med. 1990;9:515–40.

    Article  CAS  Google Scholar 

  33. Cheeseman KH, Beavis A, Esterbauer H. Hydroxyl radical induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehyde. Biochem J. 1988;252:649–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Diczfalusy U, Falardeau P, Hammarstrom S. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 1977;84:271–4.

    Article  CAS  PubMed  Google Scholar 

  35. Bucknall T, Edwards HE, Kemsley KG, Moore JS, Phillips GO. The formation of malondialdehyde in irradiated carbohydrates. Carbohydrate Res. 1978;62:49–59.

    Article  CAS  Google Scholar 

  36. Cohn JS. Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease. Curr Opin Lipidol. 2002;13:19–24.

    Article  CAS  PubMed  Google Scholar 

  37. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 1997;43:1209–14.

    CAS  PubMed  Google Scholar 

  38. Lapenna D, Ciofani G, Pierdomenico SD, Giamberardino MA, Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Rad Biol Med. 2001;31:331–5.

    Article  CAS  PubMed  Google Scholar 

  39. Martin JF, Greaves M. Vincristine inhibits the synthesis of malondialdehyde by human platelets in vitro. Cancer. 1982;49:665–8.

    Article  CAS  PubMed  Google Scholar 

  40. Nakatsuji H, Kishida K, Funahashi T. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis. 2010;212:432–45.

    Article  Google Scholar 

  41. Il’yasova D, Scarbrough P, Spasojevic I. Urinary biomarkers of oxidative status. Clin Chim Acta. 2012;413:1446–53.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

This communication is a part of PhD by research project of M. Khoubnasabjafari. Authors would like to thank Tabriz University of Medical Sciences for partial financial support.

Disclosure

The authors declare that they have no conflict of interests.

Author information

Authors and Affiliations

  1. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Maryam Khoubnasabjafari MD, PhD

  2. Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Khalil Ansarin MD

  3. Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

    Abolghasem Jouyban PharmD, PhD

Authors
  1. Maryam Khoubnasabjafari MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khalil Ansarin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abolghasem Jouyban PharmD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abolghasem Jouyban PharmD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khoubnasabjafari, M., Ansarin, K. & Jouyban, A. Comments on “An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer”. Ann Surg Oncol 24 (Suppl 3), 573–576 (2017). https://doi.org/10.1245/s10434-017-6182-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-6182-y

Search

Navigation